CDK1 is highly expressed in PBMCs of COVID-19 patients and is involved in the apoptosis process; CDK1 may also be associated with a worsening of the course of COVID-19, which is characterized by an extreme decrease in immune cells (53). The gene discussed is CDK1; the disease is COVID-19.